Oestrogen inactivation in the colon: Analysis of the expression and regulation of 17β-hydroxysteroid dehydrogenase isozymes in normal colon and colonic cancer

British Journal of Cancer

Volumn 83, Issue 4, 2000, Pages 550-558

  English, M A ^a   Hughes, S V ^a   Kane, K F ^a   Langman, M J S ^a   Stewart, P M ^a   Hewison, M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

1,25 Dihydroxyvitamin D3; 17 hydroxysteroid dehydrogenase; Colonic cancer; Oestradiol; Oestrone

Indexed keywords

DIHYDROXYCOLECALCIFEROL; ESTRADIOL; ESTROGEN; ESTRONE; ISOENZYME; MESSENGER RNA; TESTOSTERONE 17BETA DEHYDROGENASE;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; COLON; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; EPITHELIUM CELL; HORMONE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033930878     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1324     Document Type: Article

References (32)

1. Brodie A, Lu Q and Long B (1999) Aromatase and its inhibitors. J Steroid Biochem Mol Biol 69: 205-210
2. Calle EE, Miracle-McMahill HL, Thun MJ and Heath Jr CW (1995) Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 87: 517-523
3. Colditz GA (1998) Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst 90: 814-823
4. Di Domenico M, Castoria G, Bilancio A, Migliaccio A and Auricchio F (1996) Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res 56: 4516-4521
5. Elo JP, Akinola LA, Poutanen M, Vihko P, Kyllonen AP, Lukkarinen O and Vihko R (1996) Characterization of 17beta-hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate. Int J Cancer 66: 37-41
6. English MA, Kane KF, Cruickshank N, Langman MJS, Stewart PM and Hewison M (1999) Loss of estrogen inactivation in colonic cancer. J Clin Endocrinol Metab 84: 2080-2085
7. Fan L-Q, Cattley RC and Corton JC (1998) Tissue-specific induction of 17β-hydroxysteroid dehydrogenase type IV by peroxisome proliferator chemicals is dependent on the peroxisome proliferator-activator receptor α. J Endocrinol 158: 237-246
8. Fomitcheva J, Baker ME, Anderson E, Lee GY and Aziz N (1998) Characterization of ke6, a new 17 beta-hydroxysteroid dehydrogenase, and its expression in gonadal tissues. J Biol Chem 273: 22664-22671
9. Francavilla A, Dileo A, Polimeno L, Conte D, Barone M, Fanizza G, Chiumarulo C, Rizzo G and Rubino M (1987) Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding non-cancerous colonic tissue. Gastroenterol 93: 1301-1306
10. Hughes SV, Robinson E, Bland R, Lewis HM, Stewart PM and Hewison M (1997) 1 ,25-Dihydroxyvitamin D3 regulates estrogen metabolism in cultured keratinocytes. Endocrinol 138: 3711-3718
11. Jacobs E, Watson SA, Hardestle JD and Robertson JFR (1996) Oestrogen and progesterone receptors in gastrointestinal cancer cell lines. Eur J Cancer 13: 2348-2353
12. Langman MJS (1967) Current trends in the epidemiology of cancer of the colon and rectum. Proc R Soc Med 60: 210-212
13. Maentausta O, Boman K, Isomaa V, Stendahl U, Backstrom T and Vihko R (1992) Immunhistochemical study of the human 17 beta-hydroxysteroid dehydrogenase and steroid receptors in endometrial adenocarcinoma. Cancer 70: 1551-1555
14. Mann VZ, Newton CJ and Tait GH (1991) 17β-hydroxysteroid dehydrogenases in human breast tissues: purification and characterization of soluble enzymes and the distribution of particulate and soluble forms in adipose, non-adipose and tumour tissues. J Mol Endocrinol 7: 45-55
15. McDonnell DP (1999) The molecular pharmacology of SERMs. Trends Endocrinol Metab 10: 301-311
16. McMichael AJ and Potter JD (1982) Colon cancer and sex hormones. Lancet 1: 1190-1192
17. Mehta RR and Das Gupta TK (1993) Regulation of 17 bela-hydroxysteroid dehydrogenase in a newly-established human breast carcinoma cell line. J Steroid Biochem Mol Biol 46: 623-629
18. Mountford JC, Bunce CM, Hughes SV, Drayson MT, Webb D, Brown G and Hewison M (1999) Estrone potentiates myeloid cell differentiation: A role for 17β-hydroxysteroid dehdrogenase in modulating haemopoiesis. Exp Hematol 27: 451-460
19. Mustonen MVJ, Poutanen MH, Kellokumpu S, de Launoit Y, Isomaa VV, Vihko RK and Vihko PT (1998) Mouse 17 beta-hydroxysteroid dehydrogenase type 2 mRNA is predominantly expressed in hepatocytes and in surface epithelial cells of the gastrointestinal and urinary tracts. J Mol Endocrinol Metab 78: 197-204
20. Newcomb PA and Storer BE (1995) Postmenopausal hormone use and risk of large bowel cancer. J Natl Cancer Inst 87: 1067-1071
21. O'Neill JS, Elton RA and Miller WR (1988) Aromatase activity in adipose-tissue from breast quadrants - a link with tumour site. BMJ 296: 741-743
22. Osborne CK (1998) Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat 51: 227-238
23. Pasqualini JR, Chetrie G, Blacker C, Feinstein MC, Delelonde L, Talbi M and Maloche C (1996) Concentrations of estrone, estradiol and estrone sulfate and evaluation of sulfatase and aromatase activities in pre-and postmenopausal breast cancer patients. J Clin Endo Metab 81: 1460-1464
24. Peltoketo H, Isomaa V, Poutanen M and Vihko R (1996) Expression and regulation of 17β-hydroxysteroid dehydrogenase type 1. J Endocrinol 150: (Suppl): S21-S30
25. Peltoketo H, Vihko P and Vihko R (1999) Regulation of estrogen action: Role of 17 beta-hydroxysteroid dehydrogenase. Vitamins and Hormones 55: 353-398
26. Persson I, Yuen J, Bergvist L and Schairer C (1996) Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy -long term follow-up of Swedish cohort. Int J Cancer 67: 327-332
27. Puranen TJ, Kurkela RM, Lakkakorpi JT, Poutanen MH, Itaranta PV, Melis JPJ, Ghosh D, Vihko RK and Vihko PT (1999) Characterization of molecular and catalytic properties of intact and truncated human 17β-hydroxysteroid dehydrogenase type 2 enzymes: intracellular localization of the wild-type enzyme in the endoplasmic reticulum. Endocrinol 140: 3334-3341
28. Sasano H, Frost AR, Saitoh R, Harada N, Poutanen M, Vihko R, Bulun SE, Silverberg SG and Nagura H (1996) Aromatase and 17 beta-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. J Clin Endocrinol Metab 81: 4042-4046
29. Singh S, Paraskeva C, Gallimore PH, Sheppard MC and Langman MJS (1994) Differential growth response to oestrogen of prematignant and malignant colonic cell lines. Anticancer Res 14: 1037-1042
30. Singh S, Poulsom R, Hanby AM, Rogers LA, Sheppard MC and Langman MJS (1998) Expression of oestrogen receptor and oestrogen-inducible genes pS2 and ERD5 in large bowel mucosa and cancer. J Pathol 184: 153-160
31. Takeyama J, Suzuki T, Hirasawa G, Muramatsu Y, Nagura H, Iinuma K, Nakamura J, Kimura K, Yoshihama M, Harada N, Andersson S and Sasano H (2000) 17β-hydroxysteroid dehydrogenase type 1 and 2 expression in the human fetus. J Clin Endo Metab 85: 410-416
32. Xu X and Thomas ML (1994) Estrogen receptor-mediated direct stimulation of colon cancer cell growth in vitro. Mol Cell Endo 105: 197-201